Cytotoxicity, genotoxicity, transplacental transfer and tissue disposition in pregnant rats mediated by nanoparticles: the case of magnetic core mesoporous silica nanoparticles
- 24 April 2018
- journal article
- research article
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 46 (sup2) , 527-538
Abstract
Whether in the cosmetic or as therapeutic, the use of nanoparticles has been increasing and taking on global proportion. However, there are few studies about the physical potential of long-term use or use in special conditions such as chronic, AIDS, pregnant women and other special health circumstances. In this context, the study of the mutagenicity and the transplacental passage represents an important and reliable model for the primary evaluation of potential health risks, especially maternal and child health. In this study we performed mutagenicity, cytotoxic and transplacental evaluation of magnetic core mesoporous silica nanoparticles, radiolabeled with 99mTc for determination of toxicogenic and embryonic/fetuses potential risk in animal model. Magnetic core mesoporous silica nanoparticles were produced and characterized by obtaining nanoparticles with a size of (58.9 ± 8.1 nm) in spherical shape and with intact magnetic core. The 99 m Tc radiolabeling process demonstrated high efficacy and stability in 98% yield over a period of 8 hours of stability. Mutagenicity assays were performed using Salmonella enteric serovar Typhimurium standard strains TA98, TA100 and TA102. Cytotoxicity assays were performed using WST-1. The transplacental evaluation assays were performed using the in vivo model with rats in two periods: embryonic and fetal stage. The results of both analyzes corroborate that the nanoparticles can i) generate DNA damage; ii) generate cytotoxic potential and iii) cross the transplantation barrier in both stages and bioaccumulates in both embryos and fetuses. The results suggest that complementary evaluations should be conducted in order to attest safety, efficacy and quality of nanoparticles before unrestricted approval of their use. Graphical AbstractKeywords
Funding Information
- CNPq
- FAPERJ (MAT2012–38429-C04–01)
- Generalitat Valenciana (PROMETEO/2009/016)
This publication has 55 references indexed in Scilit:
- The adaptation of the blood‐brain barrier to vascular endothelial growth factor and placental growth factor during pregnancyThe FASEB Journal, 2011
- Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymesExpert Opinion on Drug Metabolism & Toxicology, 2010
- Endosomal Leakage and Nuclear Translocation of Multiwalled Carbon Nanotubes: Developing a Model for Cell UptakeNano Letters, 2009
- Maternal Uterine Vascular Remodeling During PregnancyPhysiology, 2009
- Single-walled Carbon Nanotubes: Geno- and Cytotoxic Effects in Lung Fibroblast V79 CellsJournal of Toxicology and Environmental Health, Part A, 2007
- Pregnancy-Induced Changes in PharmacokineticsClinical Pharmacokinetics, 2005
- Nanotube Molecular Transporters: Internalization of Carbon Nanotube−Protein Conjugates into Mammalian CellsJournal of the American Chemical Society, 2004
- Drug Transfer and Metabolism by the Human PlacentaClinical Pharmacokinetics, 2004
- Pharmacokinetic Changes During Pregnancy and Their Clinical RelevanceClinical Pharmacokinetics, 1997
- Placental transfer and fetal uptake of drugsJournal of Veterinary Pharmacology and Therapeutics, 1982